GANCICLOVIR

Product NDC: 63304-637
11-digit product format: 633040637
Labeler code: 63304
Product ID: 63304-637_3406db8a-5ae9-4120-94bd-036701adbeca
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: GANCICLOVIR
Dosage form: CAPSULE
Route: ORAL
Labeler: Ranbaxy Pharmaceuticals Inc.
Application: ANDA076457
Marketing category: ANDA
Marketing start: 2003-08-27
Marketing end: 0000-00-00
Substance: GANCICLOVIR
Active strength: 500 mg/1
Pharmacologic classes: Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63304-637		I	Inactivated by FDA	2026-08-03
excluded package	package	63304-637	63304-637-05	I	Inactivated by FDA	2026-08-03
excluded package	package	63304-637	63304-637-28	I	Inactivated by FDA	2026-08-03
excluded package	package	63304-637	63304-637-60	I	Inactivated by FDA	2026-08-03
excluded package	package	63304-637	63304-637-90	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 110 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-637-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-637-60	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-637-28	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-637-90	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-637-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-637-60	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-637-28	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-637-90	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-637-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-637-60	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-637-28	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-637-90	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-637-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-637-60	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-637-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-637-90	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-637-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-637-60	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-637-28	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-637-90	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-637-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-637-60	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-637-28	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-637-90	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-637-05	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-637-60	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-637-28	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-637-90	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-637-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-637-60	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-637-28	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-637-90	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-637-05	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-637-60	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-637-28	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-637-90	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-637-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-637-60	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-637-28	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-637-90	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-637-05	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-637-60	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-637-28	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-637-90	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-637-05	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-637-60	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-637-28	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-637-90	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A076457-001	GANCICLOVIR	GANCICLOVIR	250MG	CAPSULE / ORAL			2003-06-27
A076457-002	GANCICLOVIR	GANCICLOVIR	500MG	CAPSULE / ORAL			2003-06-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076457-001	GANCICLOVIR	250MG	CAPSULE / ORAL	2003-06-27	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076457-002	GANCICLOVIR	500MG	CAPSULE / ORAL	2003-06-27	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ca79b117-2321-7bf9-3481-6c7a7e8ddd86	Product name	9	20221206
9f9c8b60-edb9-4f29-9472-12fa266e8ead	Product name	5	20190912
db601a58-ade5-4a08-a9d0-73d4222e8e5a	Product name	1	20170505
af7ea8c4-c902-5a51-fdbc-62597b8c28f9	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
63304-637-05	GANCICLOVIR CAPSULES Rx only FOR ORAL ADMINISTRATION
63304-637-28	GANCICLOVIR CAPSULES Rx only FOR ORAL ADMINISTRATION
63304-637-60	GANCICLOVIR CAPSULES Rx only FOR ORAL ADMINISTRATION
63304-637-90	GANCICLOVIR CAPSULES Rx only FOR ORAL ADMINISTRATION

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63304-637-05	GANCICLOVIR	500 in 1 BOTTLE	CAPSULE	500	1
63304-637-28	GANCICLOVIR	180 in 1 BOTTLE	CAPSULE	180	1
63304-637-60	GANCICLOVIR	60 in 1 BOTTLE	CAPSULE	60	1
63304-637-90	GANCICLOVIR	90 in 1 BOTTLE	CAPSULE	90	1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63304-637-28	EA - Each	63304-637	64783516-1c72-4a60-9f23-fe7525f685b4	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GANCICLOVIR	ACTIVE INGREDIENT	P9G3CKZ4P5	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
GANCICLOVIR	ACTIVE MOIETY	P9G3CKZ4P5	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
FERRIC OXIDE BLACK	INACTIVE INGREDIENT	XM0M87F357	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
LECITHIN, SOYBEAN	INACTIVE INGREDIENT	1DI56QDM62	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
SHELLAC	INACTIVE INGREDIENT	46N107B71O	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63304-637	GANCICLOVIR CAPSULE [RANBAXY PHARMACEUTICALS INC.]	1	Legacy NDC, 4 package rows	20140710_3406db8a-5ae9-4120-94bd-036701adbeca.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
P9G3CKZ4P5	GANCICLOVIR	82410-32-0	GANCICLOVIR

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
314007	ganciclovir 250 MG Oral Capsule	PSN	3406db8a-5ae9-4120-94bd-036701adbeca	1
200206	ganciclovir 500 MG Oral Capsule	PSN	3406db8a-5ae9-4120-94bd-036701adbeca	1
314007	ganciclovir 250 MG Oral Capsule	SCD	3406db8a-5ae9-4120-94bd-036701adbeca	1
200206	ganciclovir 500 MG Oral Capsule	SCD	3406db8a-5ae9-4120-94bd-036701adbeca	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
63304-637-05	63304063705	500 in 1 BOTTLE	Historical
63304-637-28	63304063728	180 in 1 BOTTLE	Historical
63304-637-60	63304063760	60 in 1 BOTTLE	Historical
63304-637-90	63304063790	90 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GANCICLOVIR CAPSULES Rx only FOR ORAL ADMINISTRATION	Ranbaxy Pharmaceuticals Inc. \| Ranbaxy Laboratories Limited	2011-10-20	HUMAN PRESCRIPTION DRUG LABEL	1